AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2016
Apr 5, 2016
30291_dirs_2016-04-05_18a1512c-8ca3-4baa-8d72-434f215116ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2016-04-01
Reporting Person: Cox John (EVP Pharmaceutical Oper & Tech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-01 | Common Stock | A | 8444 | — | Acquired | 39045.2446 | Direct |
Footnotes
F1: Includes 84.8551 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2016.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6